Gold price continues slide, S&P 500 just shy of record high, futures up 42 points

Published 13-AUG-2020 10:01 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The S&P/ASX 200 index (XJO) struggled on Wednesday, but a late surge of around 30 points saw it finish at 6132 points, down only seven points on the day.

A steep fall in the gold price resulted in substantial downward pressure from that sector.

With the precious metal having fallen below US$1900 per ounce overnight before recovering to about US$1920 per ounce, this sector could continue to place a drag on our broader market.

What appears more likely today though is that strong performances across global equities markets will offset ructions in the mining sector where base metals also took a hit.

The ASX SPI200 futures index is up 42 points to 6130 points, suggesting that investors will focus more on the big picture.

24 hours

There were mixed performances across the Asia-Pacific markets yesterday with the Hang Seng surging 353 points or 1.4% to close at 25,244 points, while the Shanghai Composite fell 0.6% or 21 points, closing at 3319 points.

The Nikkei 225 gained 93 points to close at 22,803 points.

The mood in Europe remained decidedly positive with the FTSE 100 surging more than 2% or 125 points to 6280 points.

In mainland Europe, the DAX put on 111 points, closing at 13,058 points, while the CAC 40 recorded a similar percentage gain as it increased 45 points to 5073 points.

The positive sentiment flowed over to US markets, and it is worth noting the performance of the S&P 500 which increased 1.4% to 3380 points, just six points shy of its all-time record closing price.

To put this in perspective, the Dow gained 1% to close at 27,976 points, but it is still nearly 1600 points shy of its all-time high.

The NASDAQ returned to form with a gain of 2.1% or 229 points, once again pushing above the 11,000 point mark, bringing it within about 100 points of the record high struck earlier in the month.

Given the US remains heavily in the grip of COVID-19, while also facing a hangover of decades of financial pain, this degree of positive sentiment seems absurd.

Aside from gold, oil was one of the commodities in the spotlight, increasing from about US$44.50 per barrel to nearly US$45.50 per barrel.

Iron ore’s strong rally eased a little, gaining just 0.3% to US$121.50 per tonne.

All base metals trended lower with copper at the forefront of the retracement as it slipped for the second consecutive day to finish at US$2.90 per pound.

The Australian dollar has strengthened slightly, sitting just above US$0.715.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X